## **Core Concept**
The question pertains to the immunological approach against tumor cells, specifically focusing on the type of antibody used. Tumor cells can be targeted by various monoclonal antibodies for therapeutic or diagnostic purposes.

## **Why the Correct Answer is Right**
Monoclonal antibodies are laboratory-made molecules engineered to serve as substitute antibodies that can restore, enhance, or mimic the immune system's attack on cells. They are designed to bind to specific targets in the body. Among the given options, **.** (trastuzumab) is a well-known monoclonal antibody that targets the HER2 receptor on tumor cells, particularly in breast cancer. This specificity allows for targeted therapy, reducing harm to non-cancerous cells.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain antibodies can be used in diagnostics or treatments related to cancer, without specifying, it's hard to directly refute its relevance. However, given the specificity required for such treatments, a lack of specificity might make it less ideal.
- **Option B:** Similarly, another antibody might have applications in oncology but might not specifically target tumor cells in the way trastuzumab does for HER2-positive breast cancer cells.
- **Option D:** This option might represent another therapeutic approach or antibody not specifically tailored for targeting tumor cells in the context provided.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **trastuzumab** is specifically used for treating HER2-positive breast cancer. This highlights the importance of targeted therapy in oncology, allowing for more precise treatment with potentially fewer side effects compared to traditional chemotherapy.

## **Correct Answer:** . trastuzumab